Understanding the anti-tumor T cell responses modulation mediated by chemoradiation to improve immunotherapy efficacy

被引：0
|
作者：
Lauret, E. [1 ]
Bonin, C. [2 ]
Rangan, L. [1 ]
Boullerot, L. [3 ]
Boustani, J. [2 ]
Fagnoni-Legat, C. [4 ]
Perrin, S. [4 ]
Mirjolet, C. [5 ]
Dosset, M. [6 ]
Boidot, R. [7 ]
Servagi, S. [8 ]
De Bari, B. [2 ]
Adotevi, O. [9 ]
机构：
[1] UMR1098, Doubs, Besancon, France
[2] Univ Hosp Besancon, Radiotherapy, Besancon, France
[3] UMR1098, Besancon, France
[4] Univ Hosp Besancon, Pharm, Besancon, France
[5] Ctr GF Leclerc, Radiotherapy, Dijon, France
[6] UMR1098, Bourgogne Franche Comte, Besancon, France
[7] Ctr GF Leclerc, Mol Biol, Dijon, France
[8] Inst Jean Godinot, Radiotherapy, Reims, France
[9] UMR1098, Oncol, Besancon, France
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
92P
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [41] Vα14 NKT cell-mediated anti-tumor responses and their clinical application
    Seino, K
    Fujii, S
    Harada, M
    Motohashi, S
    Nakayama, T
    Fujisawa, T
    Taniguchi, M
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2005, 27 (01): : 65 - 74
  • [42] Vα14 NKT cell-mediated anti-tumor responses and their clinical application
    Ken-ichiro Seino
    Shin-ichiro Fujii
    Michishige Harada
    Shinichiro Motohashi
    Toshinori Nakayama
    Takehiko Fujisawa
    Masaru Taniguchi
    Springer Seminars in Immunopathology, 2005, 27 : 65 - 74
  • [43] MODULATION OF CELLULAR ANTI-TUMOR RESPONSES BY TUMOR-SPECIFIC T-SUPPRESSOR LYMPHOCYTE-TS
    HAUBECK, HD
    STUTENKEMPER, R
    KOLSCH, E
    IMMUNOBIOLOGY, 1988, 178 (1-2) : 77 - 78
  • [44] Induction of CD4+ and CD8+ anti-tumor effector T cell responses by bacteria mediated tumor therapy
    Stern, Christian
    Kasnitz, Nadine
    Kocijancic, Dino
    Trittel, Stephanie
    Riese, Peggy
    Guzman, Carlos A.
    Leschner, Sara
    Weiss, Siegfried
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (08) : 2019 - 2028
  • [45] Using machine learning and RNA to enhance the efficacy of anti-tumor immunotherapy
    Wei, Yunfang
    Su, Yingzhen
    EVOLUTIONARY INTELLIGENCE, 2023, 16 (05) : 1555 - 1563
  • [46] Using machine learning and RNA to enhance the efficacy of anti-tumor immunotherapy
    Yunfang Wei
    Yingzhen Su
    Evolutionary Intelligence, 2023, 16 : 1555 - 1563
  • [47] Understanding the anti-tumor activities of daratumumab in natural killer/T cell lymphoma (NKTCL).
    Zhou, Tianyuan
    Qing, Min
    Abraham, Yann
    Perova, Tatiana
    Sweeney, Cheryl
    Krevvata, Maria
    CANCER RESEARCH, 2021, 81 (13)
  • [48] DEVELOPMENT OF A CELL ENCAPSULATION APPROACH FOR HUMAN ANTI-TUMOR IMMUNOTHERAPY
    Schwenter, F.
    Zarei, S.
    Luy, P.
    Morel, P.
    Aebischer, P.
    Mach, N.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2008, 31 (07): : 601 - 601
  • [49] IL-12 alters T-cell metabolism to augment anti-tumor immunotherapy
    Mills, Stephanie Ann
    Dwyer, Connor
    Quinn, Kristen
    Oberholtzer, Nathan
    Chakraborty, Paramita
    Mehrotra, Shikhar
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [50] Robust Anti-Tumor T Cell Response with Efficient Intratumoral Infiltration by Nanodisc Cancer Immunotherapy
    Kuai, Rui
    Singh, Priti B.
    Sun, Xiaoqi
    Xu, Cheng
    Najafabadi, Alireza Hassani
    Scheetz, Lindsay
    Yuan, Wenmin
    Xu, Yao
    Hong, Hao
    Keskin, Derin B.
    Wu, Catherine J.
    Jain, Renu
    Schwendeman, Anna
    Moon, James J.
    ADVANCED THERAPEUTICS, 2020, 3 (09)
12345